A new business opportunity which will involve the Centre for Aquaculture technologies (CAT) collaborating with Brazilian Fish to grow genome edited tilapia is a promising landmark – both for the companies and for the aquaculture industry as a whole.
Producing sterile animals brings a wide range of advantages over producing fertile ones and genome editing is currently the most promising technique for ensuring that sterilisation is both feasible and effective.
Enhancing the efficient production of species that are relatively new to aquaculture can be done with increasingly rapid success, thanks to the growing range of tools and techniques available.
Genome edited fish are already being grown by commercial aquaculture operators in Japan, and the technology has huge potential to enhance the sector’s environmental stewardship, productivity and disease resistance.
Investing in the right genetics tools and strategies can help shrimp farming companies succeed, despite the current economic challenges, according to The Center for Aquatic Technologies (CAT).
